Toxic impacts of inhalants: Diagnosis, treatment, and clinical perspectives

Abstract

Introduction: Inhalant abuse, especially among children and adolescents, is a growing public health concern due to the severe neurotoxic and systemic effects that these substances can induce. Inhalants, which are often accessible and inexpensive, carry a significant risk of acute and chronic health problems, including irreversible damage to the central nervous system. This chapter addresses the multifaceted challenges of diagnosing and treating inhalant poisoning, highlighting the importance of early detection and intervention to mitigate the long-term consequences.

Objective: To provide a comprehensive overview of the clinical presentation, diagnostic strategies, and therapeutic approaches related to inhalant abuse. In addition, it seeks to highlight the crucial role of health professionals in identifying and managing the health impacts caused by the use of inhalants, with an emphasis on preventive measures and public health strategies.

Materials and Methods: The chapter synthesizes the current literature and clinical guidelines on inhalant abuse, using a wide range of sources, including case studies, clinical trials, and toxicological reviews. Diagnostic methods such as imaging techniques (magnetic resonance imaging and computed tomography) are discussed, as well as laboratory tests that are essential in the evaluation of patients suspected of inhalant poisoning. Therapeutic interventions, both pharmacological and non-pharmacological, are explored to provide a thorough understanding of treatment options.

Results: The findings indicate that inhalant abuse is associated with a range of neurological and systemic complications, including toxic leukoencephalopathy and metabolic disorders. Imaging studies often reveal significant brain damage, especially in chronic users, with diffuse demyelination being a common finding. Therapeutic efforts are complicated by a lack of specific antidotes, necessitating supportive care and symptomatic treatment. Preventive strategies, particularly in high-risk populations, are key to reducing the incidence and severity of health problems related to inhalant use.

Final Thoughts: Inhalant abuse remains a significant challenge in clinical practice, especially due to its widespread accessibility and the severe health outcomes associated with chronic use. Early diagnosis and intervention are crucial to prevent long-term neurological damage. This chapter emphasizes the need for comprehensive public health strategies and ongoing research to better understand the mechanisms of inhalant toxicity and to develop more effective prevention and treatment protocols. The participation of multidisciplinary teams, including health professionals, educators, and policymakers, is essential to address this complex issue and improve health outcomes for affected populations.

DOI:https://doi.org/10.56238/sevened2024.025-013